Roberto Ria
Bari, 70124, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications
Real-world evidence on infection risk in multiple myeloma treated with BiTEs and CAR-T cells: a meta-analysis.
Journal: Experimental hematology & oncology
Published: May 15, 2026
Eosinophil-linked pulmonary circulation in EGPA Improves under anti-IL-5/R therapy: A longitudinal study.
Journal: European journal of internal medicine
Published: November 28, 2025
Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe disease.
Journal: Orphanet journal of rare diseases
Published: October 23, 2025
Imaging in Plasma-Cell Neoplasms: Italian Experts' Recommendations.
Journal: European journal of haematology
Published: September 27, 2025
Successful rapid intravenous desensitization to rifampicin in a patient with tuberculosis.
Journal: Journal of infection in developing countries
Published: June 02, 2025
Progressive NK-cell dysfunction and ILC imbalance favor immune evasion in multiple myeloma.
Journal: Blood advances
Published: March 28, 2025
Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial.
Journal: Haematologica
Published: February 11, 2025
Ocular Side Effects of Dupilumab: A Comprehensive Overview of the Literature.
Journal: Journal of clinical medicine
Published: February 09, 2025
Efficacy and Safety of Mepolizumab 300 mg in Eosinophilic Granulomatosis With Polyangiitis: A Meta-Analysis of Eight Retrospective Studies.
Journal: Allergy
Published: February 04, 2025
Carfilzomib-lenalidomide-dexamethasone versus lenalidomide-dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial.
Journal: The Lancet. Haematology
Published: January 30, 2025
Last Updated: 09/26/2026